Pathological response after chemoradiotherapy. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy8

Esophagogastric Junction Lymph Nodes Larynx Axilla Breast Glottis Pelvic Bones Cells, Cultured

Organisms3

Chlamydia Mice, Inbred C57BL Mice, Knockout

Diseases66

Rectal Neoplasms Esophageal Neoplasms Carcinoma, Squamous Cell Adenocarcinoma Head and Neck Neoplasms Breast Neoplasms Neoplasm Recurrence, Local Neoplasm, Residual Nasopharyngeal Neoplasms Lymphatic Metastasis Hypopharyngeal Neoplasms Conjunctivitis Lung Neoplasms Laryngeal Neoplasms Carcinoma, Lobular Deglutition Disorders Radiation Injuries Oropharyngeal Neoplasms Carcinoma Mucositis Carcinoma, Non-Small-Cell Lung Carcinoma, Ductal, Breast Stomach Neoplasms Neoplasm Invasiveness Anus Neoplasms Uterine Cervical Neoplasms Esophagitis Otorhinolaryngologic Neoplasms Pancreatic Neoplasms Liver Neoplasms Pelvic Neoplasms Radiation Pneumonitis Stomatitis Voice Disorders Neoplasms, Squamous Cell Leukopenia Carcinoma, Small Cell Colorectal Neoplasms Muscle Neoplasms Pharyngeal Neoplasms Neoplasm Metastasis Trismus Nose Neoplasms Disease Models, Animal Carcinoma, Signet Ring Cell Disease Progression Drug-Related Side Effects and Adverse Reactions Brain Neoplasms Esophageal Fistula Tracheal Neoplasms Carcinoma, Adenosquamous Recurrence Postoperative Complications Lymphoma, Non-Hodgkin Carcinoma, Large Cell Urinary Bladder Neoplasms Mouth Neoplasms Neoplasms, Second Primary Small Cell Lung Carcinoma Neutropenia Thrombocytopenia Glioblastoma Vomiting Carcinoma, Transitional Cell Hodgkin Disease Sarcoma

Chemicals and Drugs42

Fluorouracil Cisplatin Taxoids Paclitaxel Epirubicin Deoxycytidine Organoplatinum Compounds Antineoplastic Agents Antimetabolites, Antineoplastic Doxorubicin Fluorodeoxyglucose F18 Cyclophosphamide Leucovorin Antibodies, Monoclonal, Humanized Radiopharmaceuticals Tumor Markers, Biological Carboplatin Receptors, Progesterone Anthracyclines Receptor, erbB-2 Receptors, Estrogen Hydroxyurea Antineoplastic Agents, Phytogenic Radiation-Sensitizing Agents Camptothecin Ki-67 Antigen Antibodies, Monoclonal Oxonic Acid Tegafur Etoposide Mitomycin Antineoplastic Agents, Alkylating Vinblastine Ifosfamide Vincristine Dacarbazine Amifostine Drug Combinations Triazines Melphalan Uracil Thymidylate Synthase

Analytical, Diagnostic and Therapeutic Techniques and Equipment87

Chemoradiotherapy Neoadjuvant Therapy Chemoradiotherapy, Adjuvant Combined Modality Therapy Chemotherapy, Adjuvant Radiotherapy, Adjuvant Antineoplastic Combined Chemotherapy Protocols Treatment Outcome Neoplasm Staging Esophagectomy Radiotherapy Dosage Disease-Free Survival Survival Rate Preoperative Care Survival Analysis Prognosis Retrospective Studies Radiotherapy Remission Induction Drug Administration Schedule Positron-Emission Tomography Kaplan-Meier Estimate Dose Fractionation Induction Chemotherapy Follow-Up Studies Brachytherapy Clinical Trials, Phase II as Topic Predictive Value of Tests Organ Sparing Treatments Chemotherapy, Cancer, Regional Perfusion Feasibility Studies Prospective Studies Radiotherapy, Conformal Tomography, X-Ray Computed Immunohistochemistry Digestive System Surgical Procedures Hepatectomy Biopsy Multivariate Analysis Radiotherapy, Intensity-Modulated Proportional Hazards Models Gastrectomy Laryngectomy Risk Assessment Mastectomy ROC Curve Magnetic Resonance Imaging Lymph Node Excision Lymphatic Irradiation Postoperative Care Radiotherapy, High-Energy Pneumonectomy Treatment Failure Radiation Dosage Sensitivity and Specificity Chi-Square Distribution Salvage Therapy Transplantation, Autologous Randomized Controlled Trials as Topic Bone Marrow Purging Gene Expression Profiling Dose-Response Relationship, Radiation Risk Factors Bone Marrow Transplantation Maximum Tolerated Dose Multimodal Imaging Disease Models, Animal Clinical Trials as Topic Tumor Burden Pharyngectomy Cystectomy Postoperative Period Patient Selection Probability Neck Dissection Cranial Irradiation Area Under Curve Endosonography Infusions, Intravenous Dilatation Clinical Trials, Phase III as Topic Thoracotomy Whole-Body Irradiation Fatal Outcome Preoperative Period Radiotherapy Planning, Computer-Assisted Cohort Studies

Phenomena and Processes12

Time Factors Radiation Dosage Sensitivity and Specificity Chi-Square Distribution Dose-Response Relationship, Radiation Maximum Tolerated Dose Deglutition Radiation Tolerance Probability Area Under Curve Signal Transduction Defecation

Disciplines and Occupations3

Immunohistochemistry Radiation Oncology Medical Oncology

Anthropology, Education, Sociology and Social Phenomena1

Quality of Life

Humanities1

Quality of Life

Information Science5

Survival Rate Radiotherapy, Conformal Radiotherapy, Intensity-Modulated Fatal Outcome Radiotherapy Planning, Computer-Assisted

Health Care34

Treatment Outcome Disease-Free Survival Survival Rate Preoperative Care Survival Analysis Retrospective Studies Kaplan-Meier Estimate Follow-Up Studies Clinical Trials, Phase II as Topic Predictive Value of Tests Feasibility Studies Prospective Studies Radiation Injuries Multivariate Analysis Proportional Hazards Models Risk Assessment ROC Curve Postoperative Care Treatment Failure Radiation Dosage Sensitivity and Specificity Chi-Square Distribution Randomized Controlled Trials as Topic Dose-Response Relationship, Radiation Risk Factors Clinical Trials as Topic Postoperative Period Patient Selection Probability Area Under Curve Clinical Trials, Phase III as Topic Fatal Outcome Preoperative Period Cohort Studies

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Health Care Geographicals

Chemoradiotherapy Neoadjuvant Therapy Chemoradiotherapy, Adjuvant Combined Modality Therapy Chemotherapy, Adjuvant Radiotherapy, Adjuvant Fluorouracil Antineoplastic Combined Chemotherapy Protocols Rectal Neoplasms Esophageal Neoplasms Treatment Outcome Cisplatin Neoplasm Staging Esophagectomy Carcinoma, Squamous Cell Radiotherapy Dosage Adenocarcinoma Disease-Free Survival Taxoids Survival Rate Preoperative Care Survival Analysis Head and Neck Neoplasms Paclitaxel Breast Neoplasms Epirubicin Neoplasm Recurrence, Local Prognosis Retrospective Studies Deoxycytidine Organoplatinum Compounds Antineoplastic Agents Radiotherapy Remission Induction Antimetabolites, Antineoplastic Drug Administration Schedule Doxorubicin Positron-Emission Tomography Kaplan-Meier Estimate Fluorodeoxyglucose F18 Cyclophosphamide Neoplasm, Residual Dose Fractionation Nasopharyngeal Neoplasms Induction Chemotherapy Leucovorin Antibodies, Monoclonal, Humanized Follow-Up Studies Brachytherapy Lymphatic Metastasis Hypopharyngeal Neoplasms Clinical Trials, Phase II as Topic Predictive Value of Tests Organ Sparing Treatments Conjunctivitis Chemotherapy, Cancer, Regional Perfusion Time Factors Radiopharmaceuticals Feasibility Studies Tumor Markers, Biological Lung Neoplasms Laryngeal Neoplasms Carboplatin Carcinoma, Lobular Deglutition Disorders Prospective Studies Receptors, Progesterone Radiation Injuries Oropharyngeal Neoplasms Radiotherapy, Conformal Carcinoma Anthracyclines Mucositis Tomography, X-Ray Computed Carcinoma, Non-Small-Cell Lung Immunohistochemistry Carcinoma, Ductal, Breast Receptor, erbB-2 Stomach Neoplasms Receptors, Estrogen Digestive System Surgical Procedures Hydroxyurea Antineoplastic Agents, Phytogenic Radiation-Sensitizing Agents Neoplasm Invasiveness Camptothecin Esophagogastric Junction Ki-67 Antigen Anus Neoplasms Antibodies, Monoclonal Uterine Cervical Neoplasms Hepatectomy Chlamydia Esophagitis Biopsy Otorhinolaryngologic Neoplasms Multivariate Analysis Radiotherapy, Intensity-Modulated Oxonic Acid Pancreatic Neoplasms

No FAQ available that match "pathological response after chemoradiotherapy"